HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial [Phase 1]
Phase 1 dose-escalation study assessing safety and tolerability of AAV8-delivered broadly neutralizing antibody in adults with HIV who have …
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch [Phase 3]
Phase 3 trial evaluating Doravirine + Dolutegravir as a dual therapy for HIV-1 infection in switch regimens; recruitment ongoing.
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Reducing Time to Spaced-out Appointments for Newly-diagnosed People Living With HIV [NA]
A completed clinical trial evaluating a strategy to reduce the time between spaced-out appointments for people newly diagnosed with HIV/AIDS…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Safer Conception for Women - Understanding Use of Periconception PrEP [Phase 4]
Phase 4 clinical trial update examining safer conception using periconception PrEP for women.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: InTSHA: Interactive Transition Support for HIV-infected Adolescents Using Social Media [NA]
A completed clinical trial studying interactive transition support for HIV-infected adolescents using social media; results posted in 2023.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients [Phase 4]
Phase 4 trial comparing raltegravir-based antiretroviral therapy to maintaining any other ART in HIV mono-infected patients; completed study…
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: Improving HIV Outcomes Among African American Transgender Women [NA]
A completed clinical trial focused on improving HIV outcomes among African American transgender women; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Poor Sleep and Inflammation in HIV-Infected Adults [NA]
A completed clinical trial studied poor sleep and inflammation in HIV-infected adults; results were posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Quit For Life (QFL): Smoking Cessation Among Chinese Smokers Living With HIV [NA]
Completed clinical trial evaluating Quit For Life (QFL) for smoking cessation among Chinese smokers living with HIV; results have been poste…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients [Phase 4]
Phase 4 trial update assessing a new plant-based high-energy oral nutritional supplement for malnourished patients, with multiple listed con…
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: The Shauriana Intervention for GBMSM in Kenya [NA]
This clinical trial update reports the completion of the Shauriana Intervention trial for HIV prevention among Kenyan GBMSM and notes that r…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance [Phase 4]
Phase 4 trial evaluating switching virologically suppressed HIV-1 adults with ETR resistance from etravirine to doravirine.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project [Phase 4]
Clinical trial update for a Phase 4 demonstration project assessing pre-exposure prophylaxis adherence monitoring to prevent HIV acquisition…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) [Phase 1]
Phase I open-label dose-escalation trial of a human monoclonal antibody (VRC-HIVMAB091-00-AB, N6LS) administered IV or subcutaneously with o…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis [Phase 2]
A Phase 2 trial comparing standard-dose versus double-dose dolutegravir in people with HIV-associated tuberculosis has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: A Test and Treat Strategy in New HIV Diagnosis. [Phase 3]
Phase 3 clinical trial evaluating a test-and-treat strategy in newly diagnosed HIV-1 infection has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants [Phase 3]
A Phase 3 sub-study evaluating cabotegravir and rilpivirine in HIV-1 infected participants has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed [Phase 3]
Phase 3 trial evaluating long-acting cabotegravir plus long-acting rilpivirine versus Biktarvy in virologically suppressed HIV-1 patients co…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Prevention of HIV/AIDS and STDs in Women Over Fifty [Phase 2]
Phase 2 clinical trial update on prevention of HIV/AIDS and sexually transmitted diseases in women over fifty.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: ANRS 12372 MODERATO Study [Phase 3]
Phase 3 clinical trial update for ANRS 12372 MODERATO study investigating HIV-1 infection.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy [Phase 2]
Phase 2 pharmacokinetic study evaluating levonorgestrel implant with antiretroviral therapy in HIV and contraception contexts; completed.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Lubiprostone as a Modulator of Gut Microbial Translocation in HIV With Incomplete CD4 Recovery on Antiretroviral Therapy [Phase 2]
Phase 2 clinical trial investigating lubiprostone as a modulator of gut microbial translocation in HIV patients with incomplete CD4 recovery…
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: A Clinical Trial to Evaluate the Immunogenicity of the Nonavalent Vaccine Against Human Papillomavirus in Men Infected by HIV Who Have Sex With Men. GESIDA 10017 [Phase 4]
Phase 4 trial assessing immunogenicity of the nonavalent HPV vaccine in men who have sex with men and are HIV-infected.
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: GSK3739937 First-Time-In-Human (FTIH) Study in Healthy Volunteers [Phase 1]
GSK3739937's first-in-human Phase 1 study in healthy volunteers for HIV infection has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Drug-drug Interaction (DDI) Study of GSK3640254 With Darunavir/Ritonavir (DRV/RTV) and Etravirine (ETR) [Phase 1]
This is a Phase 1 drug-drug interaction study evaluating the pharmacokinetic interactions of GSK3640254 with darunavir/ritonavir and with et…